DUBLIN--(BUSINESS WIRE)--The "IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering Technology, Application - Global Forecast to 2031" report has been added to ...
GENCURIX signs as inaugural partner to develop multiplex oncology assays for tissue and liquid biopsies Partnership aims to broaden adoption of QIAcuityDx Four platform offering clinical diagnostic ...
Next-generation molecular diagnostics are transforming disease detection, monitoring, and treatment strategies, propelling us into a new era of precision medicine. Whether identifying clinically ...
Market Growth Driven by Rising Chronic Disease Prevalence, Increasing Geriatric Population, High Burden of Infectious Diseases, and Growing Focus on Point-of-Care IVD Assays REDDING, Calif., June 30, ...
On April 29, 2023, the FDA announced a final rule on regulation of laboratory developed tests (LDTs).[1] The rule explicitly categorizes in vitro diagnostic products (IVDs) intended for clinical use ...
Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows “Accurate diagnosis, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results